Vir Biotechnology (VIR) Pension (2019 - 2020)
Vir Biotechnology's (VIR) quarterly Pension came in at $2.9 million in Q4 2020, up 52.63% year-on-year from $1.9 million in Q1 2020, and up 52.63% quarter-over-quarter from $1.9 million in Q4 2019.
Vir Biotechnology (VIR) Pension (2019 - 2020) Analysis & Trends
Vir Biotechnology has disclosed Pension across 2 years of filings, most recently posting $2.9 million for Q4 2020.
- Pension for Q4 2020 came in at $2.9 million, up 52.63% year-over-year; the trailing twelve-month figure through Dec 2020 was $2.9 million (up 52.63% YoY), and the FY2020 annual result was $2.9 million, up 52.63% from the prior year.
- Pension came in at $2.9 million for Q4 2020 at Vir Biotechnology, up from $1.9 million in the prior quarter.
- In the past five years, Pension ranged from a high of $2.9 million in Q4 2020 to a low of $1.9 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vir Biotechnology | 1.35 Bn | 1.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.90 Mn |
| Dec 31, 2019 | 1.90 Mn |